Global Lower Extremity Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2025

Summary

According to APO Research, the global Lower Extremity Exoskeleton Enhancement Device market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Lower Extremity Exoskeleton Enhancement Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Lower Extremity Exoskeleton Enhancement Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Lower Extremity Exoskeleton Enhancement Device market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Lower Extremity Exoskeleton Enhancement Device is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Lower Extremity Exoskeleton Enhancement Device market include Alter G, B-TEMIA Inc., Cyberdyne, Ekso Bionics, Hocoma, Interactive Motion Technologies, LockHeed Martin, Myomo and Panasonic, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lower Extremity Exoskeleton Enhancement Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Lower Extremity Exoskeleton Enhancement Device, also provides the sales of main regions and countries. Of the upcoming market potential for Lower Extremity Exoskeleton Enhancement Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lower Extremity Exoskeleton Enhancement Device sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Lower Extremity Exoskeleton Enhancement Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Lower Extremity Exoskeleton Enhancement Device sales, projected growth trends, production technology, application and end-user industry.

Lower Extremity Exoskeleton Enhancement Device Segment by Company

Alter G
B-TEMIA Inc.
Cyberdyne
Ekso Bionics
Hocoma
Interactive Motion Technologies
LockHeed Martin
Myomo
Panasonic
Parker Hannifin
ReWalk Robotics
US Bionics
Pharos Medical Technology
Mile Bot
Shenzhen Ruihan Medical Technology
Siyi Intelligence
Lower Extremity Exoskeleton Enhancement Device Segment by Type

Smart Type
Conventional Type
Lower Extremity Exoskeleton Enhancement Device Segment by Application

Recovery Treatment
Industrial
Others
Lower Extremity Exoskeleton Enhancement Device Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Lower Extremity Exoskeleton Enhancement Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Lower Extremity Exoskeleton Enhancement Device market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Lower Extremity Exoskeleton Enhancement Device significant trends, drivers, influence factors in global and regions.
6. To analyze Lower Extremity Exoskeleton Enhancement Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Extremity Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lower Extremity Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Extremity Exoskeleton Enhancement Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lower Extremity Exoskeleton Enhancement Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lower Extremity Exoskeleton Enhancement Device industry.
Chapter 3: Detailed analysis of Lower Extremity Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Lower Extremity Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Lower Extremity Exoskeleton Enhancement Device in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value (2020-2031)
1.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume (2020-2031)
1.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Lower Extremity Exoskeleton Enhancement Device Market Dynamics
2.1 Lower Extremity Exoskeleton Enhancement Device Industry Trends
2.2 Lower Extremity Exoskeleton Enhancement Device Industry Drivers
2.3 Lower Extremity Exoskeleton Enhancement Device Industry Opportunities and Challenges
2.4 Lower Extremity Exoskeleton Enhancement Device Industry Restraints
3 Lower Extremity Exoskeleton Enhancement Device Market by Company
3.1 Global Lower Extremity Exoskeleton Enhancement Device Company Revenue Ranking in 2024
3.2 Global Lower Extremity Exoskeleton Enhancement Device Revenue by Company (2020-2025)
3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Company (2020-2025)
3.4 Global Lower Extremity Exoskeleton Enhancement Device Average Price by Company (2020-2025)
3.5 Global Lower Extremity Exoskeleton Enhancement Device Company Ranking (2023-2025)
3.6 Global Lower Extremity Exoskeleton Enhancement Device Company Manufacturing Base and Headquarters
3.7 Global Lower Extremity Exoskeleton Enhancement Device Company Product Type and Application
3.8 Global Lower Extremity Exoskeleton Enhancement Device Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Lower Extremity Exoskeleton Enhancement Device Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Lower Extremity Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Lower Extremity Exoskeleton Enhancement Device Market by Type
4.1 Lower Extremity Exoskeleton Enhancement Device Type Introduction
4.1.1 Smart Type
4.1.2 Conventional Type
4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type
4.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Type (2020-2031)
4.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Type (2020-2031)
4.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type
4.3.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Type (2020-2031)
4.3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type (2020-2031)
5 Lower Extremity Exoskeleton Enhancement Device Market by Application
5.1 Lower Extremity Exoskeleton Enhancement Device Application Introduction
5.1.1 Recovery Treatment
5.1.2 Industrial
5.1.3 Others
5.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application
5.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume by Application (2020-2031)
5.2.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Volume Share by Application (2020-2031)
5.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application
5.3.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Application (2020-2031)
5.3.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application (2020-2031)
6 Lower Extremity Exoskeleton Enhancement Device Regional Sales and Value Analysis
6.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2020-2031)
6.2.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region: 2020-2025
6.2.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Region (2026-2031)
6.3 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region (2020-2031)
6.4.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region: 2020-2025
6.4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Region (2026-2031)
6.5 Global Lower Extremity Exoskeleton Enhancement Device Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Lower Extremity Exoskeleton Enhancement Device Sales Value (2020-2031)
6.6.2 North America Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Lower Extremity Exoskeleton Enhancement Device Sales Value (2020-2031)
6.7.2 Europe Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Value (2020-2031)
6.8.2 Asia-Pacific Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Lower Extremity Exoskeleton Enhancement Device Sales Value (2020-2031)
6.9.2 South America Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Lower Extremity Exoskeleton Enhancement Device Sales Value (2020-2031)
6.10.2 Middle East & Africa Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Country, 2024 VS 2031
7 Lower Extremity Exoskeleton Enhancement Device Country-level Sales and Value Analysis
7.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2020-2031)
7.3.1 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2020-2025)
7.3.2 Global Lower Extremity Exoskeleton Enhancement Device Sales by Country (2026-2031)
7.4 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2020-2031)
7.4.1 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2020-2025)
7.4.2 Global Lower Extremity Exoskeleton Enhancement Device Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.5.2 USA Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.6.2 Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.8.2 Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.9.2 France Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.9.3 France Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.11.2 Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.12.2 Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.13.2 Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.16.2 China Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.16.3 China Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.17.2 Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.19.2 India Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.19.3 India Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.20.2 Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.24.2 Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.26.2 Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.28.2 Israel Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.29.2 UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.31.2 Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Lower Extremity Exoskeleton Enhancement Device Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Alter G
8.1.1 Alter G Comapny Information
8.1.2 Alter G Business Overview
8.1.3 Alter G Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.1.4 Alter G Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.1.5 Alter G Recent Developments
8.2 B-TEMIA Inc.
8.2.1 B-TEMIA Inc. Comapny Information
8.2.2 B-TEMIA Inc. Business Overview
8.2.3 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.2.4 B-TEMIA Inc. Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.2.5 B-TEMIA Inc. Recent Developments
8.3 Cyberdyne
8.3.1 Cyberdyne Comapny Information
8.3.2 Cyberdyne Business Overview
8.3.3 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.3.4 Cyberdyne Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.3.5 Cyberdyne Recent Developments
8.4 Ekso Bionics
8.4.1 Ekso Bionics Comapny Information
8.4.2 Ekso Bionics Business Overview
8.4.3 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.4.4 Ekso Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.4.5 Ekso Bionics Recent Developments
8.5 Hocoma
8.5.1 Hocoma Comapny Information
8.5.2 Hocoma Business Overview
8.5.3 Hocoma Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.5.4 Hocoma Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.5.5 Hocoma Recent Developments
8.6 Interactive Motion Technologies
8.6.1 Interactive Motion Technologies Comapny Information
8.6.2 Interactive Motion Technologies Business Overview
8.6.3 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.6.4 Interactive Motion Technologies Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.6.5 Interactive Motion Technologies Recent Developments
8.7 LockHeed Martin
8.7.1 LockHeed Martin Comapny Information
8.7.2 LockHeed Martin Business Overview
8.7.3 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.7.4 LockHeed Martin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.7.5 LockHeed Martin Recent Developments
8.8 Myomo
8.8.1 Myomo Comapny Information
8.8.2 Myomo Business Overview
8.8.3 Myomo Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.8.4 Myomo Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.8.5 Myomo Recent Developments
8.9 Panasonic
8.9.1 Panasonic Comapny Information
8.9.2 Panasonic Business Overview
8.9.3 Panasonic Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.9.4 Panasonic Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.9.5 Panasonic Recent Developments
8.10 Parker Hannifin
8.10.1 Parker Hannifin Comapny Information
8.10.2 Parker Hannifin Business Overview
8.10.3 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.10.4 Parker Hannifin Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.10.5 Parker Hannifin Recent Developments
8.11 ReWalk Robotics
8.11.1 ReWalk Robotics Comapny Information
8.11.2 ReWalk Robotics Business Overview
8.11.3 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.11.4 ReWalk Robotics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.11.5 ReWalk Robotics Recent Developments
8.12 US Bionics
8.12.1 US Bionics Comapny Information
8.12.2 US Bionics Business Overview
8.12.3 US Bionics Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.12.4 US Bionics Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.12.5 US Bionics Recent Developments
8.13 Pharos Medical Technology
8.13.1 Pharos Medical Technology Comapny Information
8.13.2 Pharos Medical Technology Business Overview
8.13.3 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.13.4 Pharos Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.13.5 Pharos Medical Technology Recent Developments
8.14 Mile Bot
8.14.1 Mile Bot Comapny Information
8.14.2 Mile Bot Business Overview
8.14.3 Mile Bot Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.14.4 Mile Bot Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.14.5 Mile Bot Recent Developments
8.15 Shenzhen Ruihan Medical Technology
8.15.1 Shenzhen Ruihan Medical Technology Comapny Information
8.15.2 Shenzhen Ruihan Medical Technology Business Overview
8.15.3 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.15.4 Shenzhen Ruihan Medical Technology Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.15.5 Shenzhen Ruihan Medical Technology Recent Developments
8.16 Siyi Intelligence
8.16.1 Siyi Intelligence Comapny Information
8.16.2 Siyi Intelligence Business Overview
8.16.3 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Sales, Value and Gross Margin (2020-2025)
8.16.4 Siyi Intelligence Lower Extremity Exoskeleton Enhancement Device Product Portfolio
8.16.5 Siyi Intelligence Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Lower Extremity Exoskeleton Enhancement Device Value Chain Analysis
9.1.1 Lower Extremity Exoskeleton Enhancement Device Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Lower Extremity Exoskeleton Enhancement Device Sales Mode & Process
9.2 Lower Extremity Exoskeleton Enhancement Device Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Lower Extremity Exoskeleton Enhancement Device Distributors
9.2.3 Lower Extremity Exoskeleton Enhancement Device Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings